1. Introduction to Neuroimmunotherapies: An impressive progress towards targeted effective biologics Section 1. Special Invited Chapters: Evolution of Autoimmune Neurology 2. Autoimmune encephalitis, Autoimmune dementias and Autoimmune psychotic disorders 3. The History of Paraneoplastic Neurologic Disorders of the CNS, PNS, and Autonomic Nervous Systems: Perspective on the Past Towards a Brighter Future Section 2. Basic principles of immune activation in neurological diseases as related to targeted immunotherapies 4. Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS Neurologic diseases 5. Role of complement in neurological autoimmunities: why need to target complement activation for effective immunotherapy 6.
Paraneoplastic autoimmune neurological disorders and role of immune checkpoint inhibitors Section 3. Immunotherapeutic agents in Autoimmune Neurological Diseases: Current and evolving biologics 7. The evolution and current status of anti-B cell therapies in autoimmune Neurologic diseases 8. Evolving targeted biologics against T cells, cytokines and intracellular immune targets for multiple sclerosis with implications in other autoimmune neurological diseases 9. FcRn inhibitors: a new era in neurotherapeutics 10. Intravenous Immunoglobulin (IVIg) use in Neurology 11. HSCT for Multiple sclerosis: Improving understanding and addressing misconceptions 12. Autonomic nervous system autoimmunity and proposed immunotherapies Section 4.
Immunotherapies for specific Neurological Diseases (how do I do it): A step-by step approach based on evidence-based indications with a view to the future 13. Immunotherapies on Autoimmune Encephalitis 14. Immunotherapies in Relapsing-remitting Multiple sclerosis 15. Immunotherapies in progressive Multiple sclerosis 16. Disease Modifying Therapy in Pediatric Multiple Sclerosis 17. Immunotherapies for neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) 18. Immunotherapies in Autoimmune Movement Disorders and Cerebellar Ataxia 19. Immunobiology and Immunotherapies in Stiff-person syndrome and GAD antibody-spectrum disorders: Present and future therapeutic prospects 20.
Immunotherapies on Guillain-Barre syndrome and other Acute Autoimmune neuropathies 21. Immunotherapies in CIDP and other Chronic Autoimmune Neuropathies 22. Immunotherapy considerations for distal sensory-predominant and small fiber peripheral neuropathies 23. Immunotherapies in Autoimmune neuromuscular Junction disorders: Acute and Chronic management 24. Immunotherapies in Autoimmune Inflammatory Myopathies: Rationale and therapeutic updates 25. The Future Unfolded: CAR T Cells and the Transformation of Treatment Algorithms in Autoimmune Neurology.